NIV Aims for Indigenous H5N1 Vaccine by Year-End
National Institute of Virology director Dr Naveen Kumar reveals collaborative efforts with pharmaceutical companies to develop an indigenous vaccine candidate for highly pathogenic H5N1 avian influenza, targeting readiness by year-end.


